FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Frishman

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Devices

Defibrillators, Implantable

Procedures

Geographic Areas

United States

Activities & Behaviors

Smoking

Co-author Network

Publications

TOP 3
Alexander Papolos; William H Frishman
Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
Vinisha Garg; William H Frishman
A new potential approach to inotropic therapy in the treatment of heart failure: urocortin.
Vinisha Garg; William H Frishman
A New Approach to Inotropic Therapy in the Treatment of Heart Failure: Cardiac Myosin Activators in Treatment of HF.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Frishman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alexander Papolos; William H Frishman
Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
Cardiology in review 2013;21(3):151-4.
2013: Vinisha Garg; William H Frishman
A new potential approach to inotropic therapy in the treatment of heart failure: urocortin.
Cardiology in review 2013;21(3):160-5.
2013: Vinisha Garg; William H Frishman
A New Approach to Inotropic Therapy in the Treatment of Heart Failure: Cardiac Myosin Activators in Treatment of HF.
Cardiology in review 2013;21(3):155-9.
2013: William H Frishman; Christopher Nabors; Stephen J Peterson
Faculty supervision of the house staff handoff process: the time has come.
The American journal of medicine 2013;126(1):e1-2.
2013: William H Frishman; Franklin H Zimmerman; Robert G Lerner
Vascular and heart diseases in the incumbent presidents and vice presidents of the United States of america: a medical-historical perspective.
Cardiology in review 2013;21(1):1-8.
2012: William H Frishman; Wilbert S Aronow
Pharmacology of antiarrhythmic drugs in elderly patients.
Clinics in geriatric medicine 2012;28(4):575-615.
2012: William H Frishman
Forty years in academic cardiology.
Cardiology in review 2012;20(6):265-7.
2012: Gordon M Burke; Domenic A Sica; William H Frishman
Renal sympathetic denervation for the treatment of systemic hypertension.
Cardiology in review 2012;20(6):274-8.
2012: William H Frishman
Enhancing medical adherence.
The American journal of medicine 2012;125(9):841-2.
2012: Gurpreet Lamba; William H Frishman
Cardiac and pericardial tumors.
Cardiology in review 2012;20(5):237-52.
2012: William H Frishman; Uri Elkayam; Wilbert S Aronow
Cardiovascular drugs in pregnancy.
Cardiology clinics 2012;30(3):463-91.
2012: Alexander J Kim; William H Frishman
Laughter-induced syncope.
Cardiology in review 2012;20(4):194-6.
2012: Chandrasekar Palaniswamy; William H Frishman; Wilbert S Aronow
Carcinoid heart disease.
Cardiology in review 2012;20(4):167-76.
2012: Elizabeth Zheng; William H Frishman
The closing of St Vincent's Hospital in New York City: what happened to the house staff orphans?
The American journal of medicine 2012;125(5):e5-6.
2012: Christopher Hauck; William H Frishman
Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
Cardiology in review 2012;20(3):130-8.
2012: Christine Capone; Deborah M Friedman; Jill P Buyon; William H Frishman
Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population.
Cardiology in review 2012;20(2):72-6.
2012: Yaakov Liss; William H Frishman
Vitamin D: a cardioprotective agent?
Cardiology in review 2012;20(1):38-44.
2012: Natalia Beridze; William H Frishman
Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications.
Cardiology in review 2012;20(1):4-7.
2012: Sunit-Preet Chaudhry; William H Frishman
Myotonic dystrophies and the heart.
Cardiology in review 2012;20(1):1-3.
2011: Irene A Weiss; Noah Bloomgarden; William H Frishman
Subclinical hypothyroidism and cardiovascular risk: recommendations for treatment.
Cardiology in review 2011;19(6):291-9.
2011: Anita Kelkar; Allen Kuo; William H Frishman
Allopurinol as a cardiovascular drug.
Cardiology in review 2011;19(6):265-71.
2011: Maria M Ng; Domenic A Sica; William H Frishman
Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant hypertension.
Cardiology in review 2011;19(2):52-7.
2011: Mala Sharma; William H Frishman; Kaushang Gandhi
RESPeRATE: nonpharmacological treatment of hypertension.
Cardiology in review 2011;19(2):47-51.
2011: David Tian; William H Frishman
Vernakalant: a new drug to treat patients with acute onset atrial fibrillation.
Cardiology in review 2011;19(1):41-4.
2011: Shipra Hingorany; William H Frishman
Soluble guanylate cyclase activation with cinaciguat: a new approach to the treatment of decompensated heart failure.
Cardiology in review 2011;19(1):23-9.
2010: Kaushang Gandhi; Hoang M Lai; Harshad Amin; Wilbert S Aronow; Martin Cohen; Harit Desai; William H Frishman; Carmine Sorbera
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up.
Archives of medical science : AMS 2010;6(6):900-3.
2010: Jason Grossman; William H Frishman
Relaxin: a new approach for the treatment of acute congestive heart failure.
Cardiology in review 2010;18(6):305-12.
2010: Neil Parikh; William H Frishman
Liver x receptors: a potential therapeutic target for modulating the atherosclerotic process.
Cardiology in review 2010;18(6):269-74.
2010: Monica D Schwarcz; William H Frishman
Testosterone and coronary artery disease.
Cardiology in review 2010;18(5):251-7.
2010: Daniel F Catanzaro; William H Frishman
Angiotensin receptor blockers for management of hypertension.
Southern medical journal 2010;103(7):669-73.
2010: Harit Desai; Wilbert S Aronow; Chul Ahn; Kaushang Gandhi; Sadaf Hussain; Hoang M Lai; Mala Sharma; William H Frishman; Martin Cohen; Carmine Sorbera
Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.
The American journal of cardiology 2010;105(9):1336-8.
2010: Erdal Cavusoglu; Cyril Ruwende; Vineet Chopra; Shyam Poludasu; Sunitha Yanamadala; William H Frishman; Calvin Eng; David J Pinsky; Jonathan D Marmur
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.
Atherosclerosis 2010;210(1):226-31.
2010: Christopher Nabors; Stephen J Peterson; Wei-Nchih Lee; Arif Mumtaz; Tushar Shah; Sachin Sule; Andrew H. Gutwein; Leanne Forman; Etta Eskridge; Eric Wold; Gary W Stallings; Kathleen Kelly Burak; Carol Karmen; Caren F Behar; Christine Carosella; Shick Yu; Kausik Kar; Melissa Gennarelli; Gail Bailey-Wallace; Randy Goldberg; Gary Guo; William H Frishman
Experience with faculty supervision of an electronic resident sign-out system.
The American journal of medicine 2010;123(4):376-81.
2010: Harit Desai; Wilbert S Aronow; Chul Ahn; Fausan S Tsai; Hoang M Lai; Kaushang Gandhi; Harshad Amin; William H Frishman; Kumar Kalapatapu; Martin Cohen; Carmine Sorbera
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.
Journal of cardiovascular pharmacology and therapeutics 2010;15(1):37-40.
2010: Harit V Desai; Wilbert S Aronow; Stephen J Peterson; William H Frishman
Cardiac amyloidosis: approaches to diagnosis and management.
Cardiology in review 2010;18(1):1-11.
2010: Fausan S Tsai; Wilbert S Aronow; Srikala Devabhaktuni; Harit Desai; Adam Kruger; Hoang M Lai; William H Frishman; Martin Cohen; Carmine Sorbera
Prevalence of complications during implantation and during 38-month follow-up of 1060 consecutive patients with implantable cardioverter-defibrillators.
American journal of therapeutics 2010;17(1):e8-10.
2009: Robin Quazi; Chandrasekar Palaniswamy; William H Frishman
The emerging role of apelin in cardiovascular disease and health.
Cardiology in review 2009;17(6):283-6.
2009: Harit Desai; Wilbert S Aronow; Fausan S Tsai; Chul Ahn; Hoang M Lai; Harshad Amin; Kaushang Gandhi; William H Frishman; Martin Cohen; Carmine Sorbera
Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
Journal of cardiovascular pharmacology and therapeutics 2009;14(3):176-9.
2009: William H Frishman
Smoking cessation pharmacotherapy.
Therapeutic advances in cardiovascular disease 2009;3(4):287-308.
2009: Adam Kruger; Wilbert S Aronow; Hoang Lai; Harit Desai; Atul Singla; William H Frishman; Martin Cohen; Carmine Sorbera
Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
American journal of therapeutics 2009;16(4):323-5.
2009: Vinoy S Prasad; Chandrasekar Palaniswamy; William H Frishman
Endothelin as a clinical target in the treatment of systemic hypertension.
Cardiology in review 2009;17(4):181-91.
2009: Bredy Pierre-Louis; Aakanksha Prasad; William H Frishman
Cardiac manifestations of sarcoidosis and therapeutic options.
Cardiology in review 2009;17(4):153-8.
2009: Erdal Cavusoglu; Vineet Chopra; Amit Gupta; Palak Choksi; Cyril Ruwende; Sunitha Yanamadala; William H Frishman; David J Pinsky; Jonathan D Marmur
Relation of baseline serum potassium levels to angiographic findings in patients with known or suspected coronary artery disease.
American journal of hypertension 2009;22(7):754-62.
2009: Rena H Shah; William H Frishman
Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure.
Cardiology in review 2009;17(3):125-31.
2008: William H Frishman
beta-Adrenergic blockers: a 50-year historical perspective.
American journal of therapeutics 2008;15(6):565-76.
2008: William H Frishman
Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology.
The American journal of medicine 2008;121(11):933-4.
2008: Bredy Pierre-Louis; Parminder Singh; William H Frishman
Acute inferior wall myocardial infarction and percutaneous coronary intervention of the right coronary during active labor: a clinical report and review of the literature.
Cardiology in review 2008;16(5):260-8.
2008: William H Frishman; Rakhi Shah Barkowski
Cholesteryl ester transfer protein inhibition for coronary heart disease prevention: real hope or despair?
The American journal of medicine 2008;121(8):644-6.
2008: Hoang M Lai; Wilbert S Aronow; Adam Kruger; Harit Desai; Harshad Amin; William H Frishman; Martin Cohen; Carmine Sorbera
Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
The American journal of cardiology 2008;102(1):77-8.
2008: William H Frishman; John Horn
Statin-drug interactions: not a class effect.
Cardiology in review 2008;16(4):205-12.
2008: Daniel P Sulmasy; James E Cimino; M K He; William H Frishman
U.S. medical students' perceptions of the adequacy of their schools' curricular attention to care at the end of life: 1998-2006.
Journal of palliative medicine 2008;11(5):707-16.
2008: Jing Huang; Pawel M Kaminski; John G Edwards; Albert Yeh; Michael S Wolin; William H Frishman; Michael H Gewitz; Rajamma Mathew
Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension.
American journal of physiology. Lung cellular and molecular physiology 2008;294(6):L1250-9.
2008: Chaim Ross; William H Frishman; Stephen J Peterson; Edward Lebovics
Cardiovascular considerations in patients undergoing gastrointestinal endoscopy.
Cardiology in review 2008;16(2):76-81.
2008: William H Frishman; Sofia Novak; Lawrence J Brandt; Adam Spiegel; Andrew H. Gutwein; Maureen Kohi; Grigory Rozenblit
Pharmacologic management of mesenteric occlusive disease.
Cardiology in review 2008;16(2):59-68.
2008: Annarosa Leri; Jan Kajstura; Piero Anversa; William H Frishman
Myocardial regeneration and stem cell repair.
Current problems in cardiology 2008;33(3):91-153.
2008: William H Frishman; Linda S Henderson; Mary Ann Lukas
Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
Vascular health and risk management 2008;4(6):1387-400.
2008: Marvin S Medow; Julian Stewart; Sanjukta Sanyal; Arif Mumtaz; Domenic Sica; William H Frishman
Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope.
Cardiology in review 2008;16(1):4-20.
2007: William H Frishman; Joshua Zeidner; Nauman Naseer
Diagnosis and management of viral myocarditis.
Current treatment options in cardiovascular medicine 2007;9(6):450-64.
2007: William H Frishman
Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens.
Cardiology in review 2007;15(5):257-63.
2007: Rishi Sukhija; Wilbert S Aronow; Carmine Sorbera; Stephen J Peterson; William H Frishman; Martin Cohen
Mortality, left ventricular ejection fraction, and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with implantable cardioverter defibrillators treated with biventricular pacing versus right ventricular pacing.
American journal of therapeutics 2007;14(4):328-30.
2007: Wilbert S Aronow; William H Frishman; Angela Cheng-Lai
Cardiovascular drug therapy in the elderly.
Cardiology in review 2007;15(4):195-215.
2007: Gautham Ravipati; John A McClung; Wilbert S Aronow; Stephen J Peterson; William H Frishman
Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
Cardiology in review 2007;15(2):76-86.
2007: William H Frishman
Calcium channel blockers: differences between subclasses.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7 Suppl 1():17-23.
2007: William H Frishman
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Preventive cardiology 2007;10(2 Suppl 1):10-22.
2007: Glenn Gandelman; William H Frishman; Cristina Wiese; Vanessa Green-Gastwirth; Steven Hong; Wilbert S Aronow; Harold W Horowitz
Intravascular device infections: epidemiology, diagnosis, and management.
Cardiology in review 2007;15(1):13-23.
2006: William H Frishman; Megan Veresh; Stacy J Schlocker; Nergesh Tejani
Pathophysiology and medical management of systemic hypertension in preeclampsia.
Current hypertension reports 2006;8(6):502-11.
2006: Kerri L Palamara; Harriette R Mogul; Stephen J Peterson; William H Frishman
Obesity: new perspectives and pharmacotherapies.
Cardiology in review 2006;14(5):238-58.
2006: Victoria L Mango; William H Frishman
Physiologic, psychologic, and metabolic consequences of bariatric surgery.
Cardiology in review 2006;14(5):232-7.
2006: William H Frishman; M Veresh; Stacy J Schlocker; Nergesh Tejani
Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.
Minerva medica 2006;97(4):347-64.
2006: Robert E Feinstein; Michael Blumenfield; Barbara Orlowski; William H Frishman; Simon Ovanessian
A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease.
Cardiology in review 2006;14(4):164-9.
2006: William H Frishman; James W Hainer; Jennifer Sugg
A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
American journal of hypertension 2006;19(4):388-95.
2006: William H Frishman; Walter Mitta; Adam Kupersmith; Tom Ky
Nicotine and non-nicotine smoking cessation pharmacotherapies.
Cardiology in review 2006;14(2):57-73.
2006: Kiran Yalamanchili; Wilbert S Aronow; Ravi Kilaru; Rishi Sukhija; Sateesh Babu; Stephen J Peterson; William H Frishman
Coronary artery disease is more severe in older persons with rheumatoid arthritis than in older persons without rheumatoid arthritis.
Cardiology in review 2006;14(2):55-6.
2005: William H Frishman; Stacy J Schlocker; Ketti Awad; Nergesh Tejani
Pathophysiology and medical management of systemic hypertension in pregnancy.
Cardiology in review 2005;13(6):274-84.
2005: Rishi Sukhija; Wilbert S Aronow; Carmine Sorbera; Priyanka Kakar; Stephen J Peterson; William H Frishman; Martin Cohen
Left ventricular ejection fraction and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with automatic implantable cardioverter-defibrillators treated with dual-chamber rate-responsive pacing at a rate of 70/minute versus backup ventricular pacing at a rate of 40/minute.
The American journal of cardiology 2005;96(3):412-3.
2005: William H Frishman; James G Grattan; Ravinder Mamtani
Alternative and complementary medical approaches in the prevention and treatment of cardiovascular disease.
Current problems in cardiology 2005;30(8):383-459.
2005: Rishi Sukhija; Wilbert S Aronow; Jaisha Mathew; Kiran Yalamanchili; Priyanka Kakar; William H Frishman; Sateesh Babu
Treatment of abdominal aortic aneurysms with an endovascular stent-graft prosthesis in 96 high-risk patients.
Cardiology in review 2005;13(4):165-6.
2005: Raja Varma; Renee Garrick; John A McClung; William H Frishman
Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
Cardiology in review 2005;13(2):98-107.
2005: Rishi Sukhija; Wilbert S Aronow; Kiran Yalamanchili; Stephen J Peterson; William H Frishman; Sateesh Babu
Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease.
Cardiology 2005;103(3):158-60.
2004: William H Frishman; Andrea L Zuckerman
Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
Expert review of cardiovascular therapy 2004;2(5):675-81.
2004: William H Frishman; Charles T Stier
Aldosterone and aldosterone antagonism in systemic hypertension.
Current hypertension reports 2004;6(3):195-200.
2004: Angela Cheng-Lai; William H Frishman
Sirolimus-eluting coronary stents: novel devices for the management of coronary artery disease.
American journal of therapeutics 2004;11(3):218-28.
2004: Wilbert S Aronow; William H Frishman
Treatment of hypertension and prevention of ischemic stroke.
Current cardiology reports 2004;6(2):124-9.
2003: Adrian Fluture; Shobhana Chaudhari; William H Frishman
Valvular heart disease and systemic lupus erythematosus: therapeutic implications.
Heart disease (Hagerstown, Md.) 2003;5(5):349-53.
2003: William H Frishman
Cardiology patient page. Beta-adrenergic blockers.
Circulation 2003;107(18):e117-9.
2003: Nauman Naseer; Wilbert S Aronow; John A McClung; Shirin Sanal; Stephen J Peterson; Melvin B Weiss; William H Frishman
Circumflex coronary artery occlusion after blunt chest trauma.
Heart disease (Hagerstown, Md.) 2003;5(3):184-6.
2003: Joydeep Ghosh; Melvin B Weiss; Richard H Kay; William H Frishman
Diabetes mellitus and coronary artery disease: therapeutic considerations.
Heart disease (Hagerstown, Md.) 2003;5(2):119-28.
2003: William H Frishman; Victor Azer; Domenic Sica
Drug treatment of orthostatic hypotension and vasovagal syncope.
Heart disease (Hagerstown, Md.) 2003;5(1):49-64.
2002: William H Frishman
An odyssey of a clinical researcher.
Heart disease (Hagerstown, Md.) 2002;4(6):392-6.
2002: William H Frishman
Are antihypertensive agents protective against dementia? A review of clinical and preclinical data.
Heart disease (Hagerstown, Md.) 2002;4(6):380-6.
2002: William H Frishman; Brian D Brosnan; Marc Grossman; Debasish Dasgupta; Diana K Sun
Adverse dermatologic effects of cardiovascular drug therapy: part III.
Cardiology in review 2002;10(6):337-48.
2002: William H Frishman; Brian D Brosnan; Marc Grossman; Debasish Dasgupta; Diana K Sun
Adverse dermatologic effects of cardiovascular drug therapy: part II.
Cardiology in review 2002;10(5):285-300.
2002: Mark H Friedman; Stephen J Peterson; William H Frishman; Caren F Behar
Intraoral topical nonsteroidal antiinflammatory drug application for headache prevention.
Heart disease (Hagerstown, Md.) 2002;4(4):212-5.
2002: William H Frishman; Brian D Brosnan; Marc Grossman; Debasish Dasgupta; And Diana K Sun
Adverse dermatologic effects of cardiovascular drug therapy: part I.
Cardiology in review 2002;10(4):230-46.
2002: William H Frishman; And Anjum Ismail
Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?
Cardiology in review 2002;10(4):199-210.
2002: William H Frishman; Miechelle O'Brien; Nauman Naseer; Sharmila Anandasabapathy
Innovative drug treatments for viral and autoimmune myocarditis.
Heart disease (Hagerstown, Md.) 2002;4(3):171-83.
2002: William H Frishman
Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema.
The American journal of cardiology 2002;89(6A):18D-25D.
2002: Gary T Midelton; William H Frishman; Stanley S Passo
Congestive heart failure and continuous positive airway pressure therapy: support of a new modality for improving the prognosis and survival of patients with advanced congestive heart failure.
Heart disease (Hagerstown, Md.) 2002;4(2):102-9.
2002: William H Frishman; Mamata Alwarshetty
Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.
Clinical pharmacokinetics 2002;41(7):505-16.
2001: William H Frishman; M Kowalski; S Nagnur; S Warshafsky; Domenic Sica
Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
Heart disease (Hagerstown, Md.) 2001;3(6):386-97.
2001: William H Frishman; T Ky; A Ismail
Tobacco smoking, nicotine, and nicotine and non-nicotine replacement therapies.
Heart disease (Hagerstown, Md.) 2001;3(6):365-77.
2001: N Guttenplan; C Lee; William H Frishman
Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibition.
Heart disease (Hagerstown, Md.) 2001;3(5):313-8.
2001: Nauman Naseer; A Aijaz; Mohammad A Saleem; J Nelson; Stephen J Peterson; William H Frishman
Ticlopidine-associated thrombotic thrombocytopenic purpura.
Heart disease (Hagerstown, Md.) 2001;3(4):221-3.
2001: S Kaur; William H Frishman; I Singh; P Tamirisa; A Kumar
Endothelin as a therapeutic target in the treatment of cardiovascular disease.
Heart disease (Hagerstown, Md.) 2001;3(3):176-88.
2001: T Kelsch; K Kikuchi; S Vahdat; William H Frishman
Innovative pharmacologic approaches to cardiopulmonary resuscitation.
Heart disease (Hagerstown, Md.) 2001;3(1):46-54.
2001: Devraj Nayak; C Karmen; William H Frishman; B A Vakili
Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease.
Heart disease (Hagerstown, Md.) 2001;3(1):28-45.
2000: James J Lah; William H Frishman
Adrenomedullin: a vasoactive and natriuretic peptide with therapeutic potential.
Heart disease (Hagerstown, Md.) 2000;2(3):259-65.
2000: Brian D Brosnan; William H Frishman; Diana K Sun; Marc Grossman
Adverse dermatologic effects of cardiovascular drug therapy.
Heart disease (Hagerstown, Md.) 2000;2(3):220-47.
2000: William H Frishman
Recent advances in cardiovascular pharmacology.
Current problems in cardiology 2000;25(4):227-95.
2000: K Awad; P Ali; William H Frishman; Nergesh Tejani
Pharmacologic approaches for the management of systemic hypertension in pregnancy.
Heart disease (Hagerstown, Md.) 2000;2(2):124-32.
2000: S A Palkhiwala; A Yu; William H Frishman
Imidazoline receptor agonist drugs for treatment of systemic hypertension and congestive heart failure.
Heart disease (Hagerstown, Md.) 2000;2(1):83-92.
1999: William H Frishman
Recent advances in cardiovascular pharmacology.
Heart disease (Hagerstown, Md.) 1999;1(2):68-90.
1999: William H Frishman; S Glasser; P Stone; P C Deedwania; M Johnson; T D Fakouhi
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
The American journal of cardiology 1999;83(4):507-14.
1998: William H Frishman; R Chiu; B R Landzberg; M Weiss
Medical therapies for the prevention of restenosis after percutaneous coronary interventions.
Current problems in cardiology 1998;23(10):534-635.